Inhibiting mechanotransduction for the treatment of pancreatic cancer

Project Information

TALVIN

Grant agreement ID: 801180

DOI 10.3030/801180

Project closed

EC signature date 4 May 2018

Start date 1 September 2018

End date 29 February 2020

Funded under

• EXCELLENT SCIENCE - Future and Emerging Technologies (FET)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Spain